Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinosarcoma × olaparib × Clear all

Phase

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 12 Endometrial Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Neoplasms 3 Breast Neoplasms 3 Uterine Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Mesothelioma 1 Laryngeal Neoplasms 1 Kenny-Caffey syndrome, Type 1 1 Hyperglycemia 1 High Grade Serous Ovarian Cancer 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1

Interventions

Paclitaxel 2 olaparib 1 cediranib 1 apatinib 1 Taxes 1 Nivolumab 1 Ifosfamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown

GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡